Search research articles
Contact Us
Filters
Showing results (131-140 of 149) with videos related to
Page
of 15
Sort By:
Investigational New Drugs
|
August 19, 2011
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death
Agata M Wasik, Michael N Gandy, Matthew McIldowie, et al.
Journal for Immunotherapy of Cancer
|
August 4, 2025
Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial
Danial Khan Hadi, Kelly J Baines, Behnam Jabbarizadeh, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 3, 2017
Design, synthesis and SAR of new-di-substituted pyridopyrimidines as ATP-competitive dual PI3Kα/mTOR inhibitors
Aisha A K Al-Ashmawy, Fatma A Ragab, Khaled M Elokely, et al.
ALTEX
|
December 7, 2021
U.S. Federal Agency interests and key considerations for new approach methodologies for nanomaterials
Elijah J Petersen, Patricia Ceger, David G Allen, et al.
Regulatory Toxicology and Pharmacology : RTP
|
May 13, 2019
Exploring current read-across applications and needs among selected U.S. Federal Agencies
Grace Patlewicz, Lucina E Lizarraga, Diego Rua, et al.
ACS Medicinal Chemistry Letters
|
December 17, 2021
Discovery of Imidazole-Based Inhibitors of <i>Plasmodium falciparum</i> cGMP-Dependent Protein Kinase
Rammohan R Yadav Bheemanaboina, Mariana Laureano de Souza, Mariana Lozano Gonzalez, et al.
Journal of Medicinal Chemistry
|
February 19, 2024
Structure-Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials
John A Gilleran, Kutub Ashraf, Melvin Delvillar, et al.
Journal of Medicinal Chemistry
|
October 22, 2025
RTx-303, an Orally Bioavailable Polθ Polymerase Inhibitor That Potentiates PARP Inhibitors in BRCA Mutant Tumors
Gurushankar Chandramouly, William Fried, John Gordon, et al.
Nature Communications
|
April 5, 2024
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
William Fried, Mrityunjay Tyagi, Leonid Minakhin, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
May 10, 2020
Variability in deceased donor care in Canada: a report of the Canada-DONATE cohort study
Frédérick D'Aragon, Francois Lamontagne, Deborah Cook, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 149) with videos related to
Sort By:
Page
of 15
Investigational New Drugs
|
August 19, 2011
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death
Agata M Wasik, Michael N Gandy, Matthew McIldowie, et al.
Journal for Immunotherapy of Cancer
|
August 4, 2025
Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial
Danial Khan Hadi, Kelly J Baines, Behnam Jabbarizadeh, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 3, 2017
Design, synthesis and SAR of new-di-substituted pyridopyrimidines as ATP-competitive dual PI3Kα/mTOR inhibitors
Aisha A K Al-Ashmawy, Fatma A Ragab, Khaled M Elokely, et al.
ALTEX
|
December 7, 2021
U.S. Federal Agency interests and key considerations for new approach methodologies for nanomaterials
Elijah J Petersen, Patricia Ceger, David G Allen, et al.
Regulatory Toxicology and Pharmacology : RTP
|
May 13, 2019
Exploring current read-across applications and needs among selected U.S. Federal Agencies
Grace Patlewicz, Lucina E Lizarraga, Diego Rua, et al.
ACS Medicinal Chemistry Letters
|
December 17, 2021
Discovery of Imidazole-Based Inhibitors of <i>Plasmodium falciparum</i> cGMP-Dependent Protein Kinase
Rammohan R Yadav Bheemanaboina, Mariana Laureano de Souza, Mariana Lozano Gonzalez, et al.
Journal of Medicinal Chemistry
|
February 19, 2024
Structure-Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials
John A Gilleran, Kutub Ashraf, Melvin Delvillar, et al.
Journal of Medicinal Chemistry
|
October 22, 2025
RTx-303, an Orally Bioavailable Polθ Polymerase Inhibitor That Potentiates PARP Inhibitors in BRCA Mutant Tumors
Gurushankar Chandramouly, William Fried, John Gordon, et al.
Nature Communications
|
April 5, 2024
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
William Fried, Mrityunjay Tyagi, Leonid Minakhin, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
May 10, 2020
Variability in deceased donor care in Canada: a report of the Canada-DONATE cohort study
Frédérick D'Aragon, Francois Lamontagne, Deborah Cook, et al.
Page
of 15